These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1441 related items for PubMed ID: 20098330

  • 1. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J.
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
    Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO.
    Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
    [Abstract] [Full Text] [Related]

  • 3. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
    Jung G, Poll L, Cohnen M, Saleh A, Vogler H, Wettstein M, Willers R, Mödder U, Koch JA.
    Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
    [Abstract] [Full Text] [Related]

  • 4. Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation.
    Böttcher J, Hansch A, Pfeil A, Schmidt P, Malich A, Schneeweiss A, Maurer MH, Streitparth F, Teichgräber UK, Renz DM.
    Eur J Radiol; 2013 Nov; 82(11):1860-9. PubMed ID: 23932636
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, Casalino DD, Davis PL, Francis IR, Krinsky G, Lee FT, Lu D, Paulson EK, Schwartz LH, Siegelman ES, Small WC, Weber TM, Welber A, Shamsi K.
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [Abstract] [Full Text] [Related]

  • 6. Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA.
    Jung G, Breuer J, Poll LW, Koch JA, Balzer T, Chang S, Mödder U.
    Acta Radiol; 2006 Feb; 47(1):15-23. PubMed ID: 16498928
    [Abstract] [Full Text] [Related]

  • 7. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
    Vogl TJ, Schwarz W, Blume S, Pietsch M, Shamsi K, Franz M, Lobeck H, Balzer T, del Tredici K, Neuhaus P, Felix R, Hammerstingl RM.
    Eur Radiol; 2003 Feb; 13(2):262-72. PubMed ID: 12598989
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ, Hammerstingl R, Schwarz W, Kümmel S, Müller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R.
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [Abstract] [Full Text] [Related]

  • 9. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D.
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [Abstract] [Full Text] [Related]

  • 10. Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography.
    Kwak HS, Lee JM, Kim CS.
    Eur Radiol; 2004 Mar; 14(3):447-57. PubMed ID: 14531005
    [Abstract] [Full Text] [Related]

  • 11. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
    Li J, Wang J, Lei L, Yuan G, He S.
    Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
    [Abstract] [Full Text] [Related]

  • 12. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R.
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [Abstract] [Full Text] [Related]

  • 13. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
    Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, Laniado M, Manfredi RM, Mathieu DG, Mueller D, Reimer P, Robinson PJ, Strotzer M, Taupitz M, Vogl TJ, European EOB Study Group.
    Radiology; 2004 Jan; 230(1):266-75. PubMed ID: 14695400
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.
    Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, Fusté LC, Heinz-Peer G, Judmaier W, Laniado M, Manfredi RM, Mathieu DG, Müller D, Mortelè K, Reimer P, Reiser MF, Robinson PJ, Shamsi K, Strotzer M, Taupitz M, Tombach B, Valeri G, van Beers BE, Vogl TJ, European EOB-study group.
    Eur Radiol; 2008 Mar; 18(3):457-67. PubMed ID: 18058107
    [Abstract] [Full Text] [Related]

  • 15. Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial.
    Raman SS, Leary C, Bluemke DA, Amendola M, Sahani D, McTavish JD, Brody J, Outwater E, Mitchell D, Sheafor DH, Fidler J, Francis IR, Semelka RC, Shamsi K, Gschwend S, Feldman DR, Breuer J, United States EOB Study Group.
    J Comput Assist Tomogr; 2010 Mar; 34(2):163-72. PubMed ID: 20351497
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D.
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [Abstract] [Full Text] [Related]

  • 17. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M, Marin D, Guerrisi A, Baski M, Galati F, Rossi M, Brozzetti S, Masciangelo R, Passariello R, Catalano C.
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [Abstract] [Full Text] [Related]

  • 18. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners.
    Limanond P, Raman SS, Sayre J, Lu DS.
    J Magn Reson Imaging; 2004 Oct; 20(4):640-7. PubMed ID: 15390231
    [Abstract] [Full Text] [Related]

  • 19. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    Wang YC, Chou CT, Lin CP, Chen YL, Chen YF, Chen RC.
    PLoS One; 2017 Oct; 12(3):e0174594. PubMed ID: 28355258
    [Abstract] [Full Text] [Related]

  • 20. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.